Crossmark

Killed whole-cell Staphylococcus aureus formulation in Montanide ISA266 and Alum adjuvants: different vaccine formulations varied in the vaccine’s potency and efficacy

Crossref DOI link: https://doi.org/10.1007/s12026-025-09602-z

Published Online: 2025-02-07

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bagherzadeh, Mandana

Haghighat, Setareh

Mahdavi, Mehdi
License Information

Text and Data Mining valid from 2025-02-07

Version of Record valid from 2025-02-07
More Information

Article History

Received: 25 September 2024

Accepted: 31 January 2025

First Online: 7 February 2025

Declarations

:

: Animal study protocols were found to follow ethical principles, national norms, and standards for conducting Medical Research in Iran. The Islamic Azad Tehran Medical Sciences University-Pharmacy and Pharmaceutical Branches Faculty approved all experimental procedures.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below